InvestorsHub Logo
Followers 127
Posts 19706
Boards Moderated 1
Alias Born 07/15/2010

Re: None

Thursday, 05/25/2023 12:52:40 AM

Thursday, May 25, 2023 12:52:40 AM

Post# of 65446
This right here.

$TSOI hope leadership finally refrains from further incessant verbal expressions and disruptive commentary! In the United States, when a biotech company submits an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA), it is customary for the FDA to provide confirmation of receipt to the submitting company. This confirmation typically serves as acknowledgment that the FDA has received the IND request.
However, it is important to note that the specific processes and communication protocols may vary between different biotech companies and the FDA. It is recommended for the biotech company to maintain open and regular communication with the FDA regarding the status of their submission. If there are concerns about the IND application not being sent or received by the FDA, it would be advisable for the biotech company to directly reach out to the FDA for clarification and confirmation.

all in my opinion...but likely fact.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News